Capital Fund Management S.A.
Source: SEC Form 13F · as of Mar 2026Capital Fund Management S.A. holds 26 biotech & pharma companies tracked by BioSniper, totaling $203.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$203.6M
BioSniper AIPage context preserved
Prepared research question
What matters most for ALNYLAM PHARMACEUTICALS, INC. (ALNY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALNYALNYLAM PHARMACEUTICALS, INC. | 140,109 | $46.4M |
| INCYIncyte Corp. | 312,021 | $29.4M |
| MRNAModerna, Inc. | 569,930 | $29.0M |
| EXELEXELIXIS, INC. | 479,693 | $20.6M |
| IONSIONIS PHARMACEUTICALS INC | 142,201 | $10.7M |
| GILDGILEAD SCIENCES, INC. | 73,592 | $10.3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 181,065 | $10.2M |
| NTLAIntellia Therapeutics, Inc. | 730,122 | $9.4M |
| PTCTPTC THERAPEUTICS, INC. | 121,286 | $8.3M |
| RXRXRECURSION PHARMACEUTICALS, INC. | 1,909,480 | $5.9M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 129,531 | $4.4M |
| TGTXTG THERAPEUTICS, INC. | 112,684 | $3.7M |
| APLSApellis Pharmaceuticals, Inc. | 68,112 | $2.7M |
| TVTXTravere Therapeutics, Inc. | 85,881 | $2.6M |
| GPCRStructure Therapeutics Inc. | 32,436 | $1.6M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 29,715 | $1.5M |
| GMABGenmab A/S | 55,399 | $1.5M |
| LQDALiquidia Corp | 34,222 | $1.3M |
| ARDXARDELYX, INC. | 165,498 | $991K |
| SLNOSOLENO THERAPEUTICS INC | 26,511 | $888K |
| VKTXViking Therapeutics, Inc. | 20,824 | $678K |
| ROIVRoivant Sciences Ltd. | 17,297 | $479K |
| ADPTAdaptive Biotechnologies Corp | 34,473 | $478K |
| HROWHARROW, INC. | 11,258 | $397K |
| BHVNBiohaven Ltd. | 29,989 | $254K |
| MLTXMoonLake Immunotherapeutics | 11,260 | $210K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.